User:Mr. Ibrahem/Ramucirumab

Ramucirumab, sold under the brand name Cyramza, is a medication used to treat stomach cancer, colorectal cancer, non-small cell lung cancer, and hepatocellular cancer. It is only used in certain advanced cases. It is given by injection into a vein.

Common side effects include tiredness, diarrhea, bleeding, headache, low sodium, swelling, and kidney problems. Other side effects may include gastrointestinal perforation, poor wound healing, high blood pressure, and blood clots. Use in pregnancy may harm the baby. It is a monoclonal antibody that attaches to vascular endothelial growth factor receptor (VEGFR) blocking its action.

Ramucirumab was approved for medical use in the United States and Europe in 2014. In the United States 500 mg costs about 6,600 USD as of 2021. In the United Kingdom this amount costs the NHS about £2,500.